Assessing the utility of incorporation of clinical and histopathologic features for risk stratification in plaque-stage folliculotropic mycosis fungoides: A retrospective validation study
Journal of the American Academy of Dermatology · 2025-08 · 93 (2) · 398-405
DOI: 10.1016/j.jaad.2025.04.059 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Journal of the American Academy of Dermatology, 2025-08. Verfasst von Amanda J Nguyen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Hauptthemen laut MEDLINE: Mycosis Fungoides, Skin Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: A recently proposed staging system for folliculotropic mycosis fungoides (FMF) used clinical and histopathologic data to define 2 prognostic classes (ie early, advanced) for plaque-stage disease. OBJECTIVE: In this external retrospective single-center cohort, we assessed the prognostic ability of the proposed re-classification system and high-risk histopathologic features overall. METHODS: Patients with FMF were staged clinically. Skin biopsy specimens were reviewed for high-risk features. Patients with plaque-stage FMF were subcategorized as having early or advanced disease. RESULTS: Of 81 patients with FMF (early-stage, n = 43; advanced-stage, n = 38), 40 had plaque-stage FMF (early plaque-stage, n = 24; advanced plaque-stage, n = 16). There was no difference in overall survival between early and advanced plaque-stage FMF. Of all cases, univariate analysis revealed associations between angioinvasion/angiodestruction and overall survival (hazard ratio, 6.04; 95% CI, 1.88-19.42; P = .003) and disease-specific survival (hazard ratio, 7.17; 95% CI, 1.76-29.33; P = .006), and between large cell transformation and disease-specific survival (hazard ratio, 4.91; 95% CI, 1.47-16.35; P = .010). LIMITATIONS: Few disease-specific deaths in the plaque-stage subgroup precluded analysis of disease-specific survival. CONCLUSION: In this cohort, addition of histopathologic data to subdivide plaque-stage FMF into early and advanced groups added no prognostic value. However, certain histopathologic features including angioinvasion/angiodestruction and large-cell transformation did offer prognostic power overall.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
- Department of Dermatology, Mayo Clinic, Rochester, Minnesota.
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; Department of Dermatology, Mayo Clinic, Rochester, Minnesota.
- Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota.
- Department of Dermatology, Mayo Clinic, Jacksonville, Florida; Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, Florida. Electronic address: Sokumbi.Olayemi@mayo.edu.
Zitieren
APA
Nguyen, A. J., Link, J. L., Johnson, E. F., Todd, A., Lehman, J. S., Comfere, N. I., & Sokumbi, O. (2025). Assessing the utility of incorporation of clinical and histopathologic features for risk stratification in plaque-stage folliculotropic mycosis fungoides: A retrospective validation study. Journal of the American Academy of Dermatology, 93(2), 398-405. https://doi.org/10.1016/j.jaad.2025.04.059
Vancouver
Nguyen AJ, Link JL, Johnson EF, Todd A, Lehman JS, Comfere NI, et al. Assessing the utility of incorporation of clinical and histopathologic features for risk stratification in plaque-stage folliculotropic mycosis fungoides: A retrospective validation study. Journal of the American Academy of Dermatology. 2025;93(2):398-405. doi:10.1016/j.jaad.2025.04.059
BibTeX
@article{Nguyen2025,
author = {Nguyen, Amanda J and Link, Jenny L and Johnson, Emma F and Todd, Austin and Lehman, Julia S and Comfere, Nneka I and Sokumbi, Olayemi},
title = {Assessing the utility of incorporation of clinical and histopathologic features for risk stratification in plaque-stage folliculotropic mycosis fungoides: A retrospective validation study},
journal = {Journal of the American Academy of Dermatology},
year = {2025},
volume = {93},
number = {2},
pages = {398--405},
doi = {10.1016/j.jaad.2025.04.059}
}
EUVIMED